ARTICLE | Company News
Cognosci, Oncotide deal
April 11, 2011 7:00 AM UTC
Cognosci spun-out newco Oncotide to discover and develop protein phosphatase modulators to treat cancer. Cognosci granted Oncotide an exclusive license for IP covering its cancer pipeline, and provide...